These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 25647155)

  • 1. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
    Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
    Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
    J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
    Vaughn BP; Vatanen T; Allegretti JR; Bai A; Xavier RJ; Korzenik J; Gevers D; Ting A; Robson SC; Moss AC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2182-90. PubMed ID: 27542133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
    Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
    Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis.
    Suskind DL; Singh N; Nielson H; Wahbeh G
    J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):27-9. PubMed ID: 25162366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Kong L; Lloyd-Price J; Vatanen T; Seksik P; Beaugerie L; Simon T; Vlamakis H; Sokol H; Xavier RJ
    Gastroenterology; 2020 Dec; 159(6):2193-2202.e5. PubMed ID: 32860788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease.
    Li P; Zhang T; Xiao Y; Tian L; Cui B; Ji G; Liu YY; Zhang F
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):349-360. PubMed ID: 30357440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.
    Suskind DL; Cohen SA; Brittnacher MJ; Wahbeh G; Lee D; Shaffer ML; Braly K; Hayden HS; Klein J; Gold B; Giefer M; Stallworth A; Miller SI
    J Clin Gastroenterol; 2018 Feb; 52(2):155-163. PubMed ID: 28030510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
    Yang Z; Bu C; Yuan W; Shen Z; Quan Y; Wu S; Zhu C; Wang X
    Dig Dis Sci; 2020 Jan; 65(1):150-157. PubMed ID: 31367877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile.
    Kao D; Hotte N; Gillevet P; Madsen K
    J Clin Gastroenterol; 2014 Aug; 48(7):625-8. PubMed ID: 24667590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation for Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Wei W; Li Z
    Tech Coloproctol; 2021 May; 25(5):495-504. PubMed ID: 33759066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
    Kump PK; Gröchenig HP; Lackner S; Trajanoski S; Reicht G; Hoffmann KM; Deutschmann A; Wenzl HH; Petritsch W; Krejs GJ; Gorkiewicz G; Högenauer C
    Inflamm Bowel Dis; 2013 Sep; 19(10):2155-65. PubMed ID: 23899544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile.
    Gutin L; Piceno Y; Fadrosh D; Lynch K; Zydek M; Kassam Z; LaMere B; Terdiman J; Ma A; Somsouk M; Lynch S; El-Nachef N
    United European Gastroenterol J; 2019 Jul; 7(6):807-814. PubMed ID: 31316785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
    Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease.
    Lv Y; Zhen C; Liu A; Hu Y; Yang G; Xu C; Lou Y; Cheng Q; Luo Y; Yu J; Fang Y; Zhao H; Peng K; Yu Y; Lou J; Chen J; Ni Y
    mSystems; 2024 Sep; 9(9):e0078324. PubMed ID: 39150251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study.
    Sokol H; Landman C; Seksik P; Berard L; Montil M; Nion-Larmurier I; Bourrier A; Le Gall G; Lalande V; De Rougemont A; Kirchgesner J; Daguenel A; Cachanado M; Rousseau A; Drouet É; Rosenzwajg M; Hagege H; Dray X; Klatzman D; Marteau P; ; Beaugerie L; Simon T
    Microbiome; 2020 Feb; 8(1):12. PubMed ID: 32014035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
    Kunde S; Pham A; Bonczyk S; Crumb T; Duba M; Conrad H; Cloney D; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):597-601. PubMed ID: 23542823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn's disease.
    Li Y; Sun R; Lai C; Liu K; Yang H; Peng Z; Xu D; Huang F; Tang K; Peng Y; Liu X
    J Transl Med; 2024 May; 22(1):518. PubMed ID: 38816750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study.
    Wang H; Cui B; Li Q; Ding X; Li P; Zhang T; Yang X; Ji G; Zhang F
    Adv Ther; 2018 Nov; 35(11):1935-1944. PubMed ID: 30328062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass.
    He Z; Li P; Zhu J; Cui B; Xu L; Xiang J; Zhang T; Long C; Huang G; Ji G; Nie Y; Wu K; Fan D; Zhang F
    Sci Rep; 2017 Jul; 7(1):4753. PubMed ID: 28684845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.